Wang SJ - Search Results

1

[Experimental study of the function of nuclear factor-κB-dependent epithelial to mesenchymal transition in pancreatic cancer cells under hypoxic conditions].

Cheng ZX, Sun B, Wang SJ, Zhou HX, Jia G, Kong R, Wang G, Jiang HC. Cheng ZX, et al. Among authors: wang g, wang sj. Zhonghua Wai Ke Za Zhi. 2012 May;50(5):446-51. Zhonghua Wai Ke Za Zhi. 2012. PMID: 22883954 Chinese.

2

Downregulation of nuclear factor-kappaB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer.

Kong R, Sun B, Jiang H, Pan S, Chen H, Wang S, Krissansen GW, Sun X. Kong R, et al. Cancer Lett. 2010 May 1;291(1):90-8. doi: 10.1016/j.canlet.2009.10.001. Epub 2009 Oct 31. Cancer Lett. 2010. PMID: 19880242

3

Effects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats.

Chen P, Sun B, Chen H, Wang G, Pan S, Kong R, Bai X, Wang S. Chen P, et al. Cytokine. 2010 Jan;49(1):15-23. doi: 10.1016/j.cyto.2009.09.013. Epub 2009 Nov 8. Cytokine. 2010. PMID: 19900821

4

Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB.

Chen H, Sun B, Wang S, Pan S, Gao Y, Bai X, Xue D. Chen H, et al. J Cancer Res Clin Oncol. 2010 Jun;136(6):897-903. doi: 10.1007/s00432-009-0731-0. Epub 2009 Nov 26. J Cancer Res Clin Oncol. 2010. PMID: 19941148

5

Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo.

Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, Xue DB, Bai XW, Sun B. Wang SJ, et al. Cancer Lett. 2010 Jul 1;293(1):99-108. doi: 10.1016/j.canlet.2010.01.001. Epub 2010 Feb 4. Cancer Lett. 2010. PMID: 20137856

6

[An experimental study of gemcitabine inducing pancreatic cancer cell apoptosis potentiated by nuclear factor-kappa B P65 siRNA].

Kong R, Sun B, Wang SJ, Pan SH, Wang G, Chen H, Xue DB, Jiang HC. Kong R, et al. Among authors: wang g, wang sj. Zhonghua Wai Ke Za Zhi. 2010 Jan 15;48(2):128-33. Zhonghua Wai Ke Za Zhi. 2010. PMID: 20302733 Chinese.

7

[Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer].

Wang SJ, Sun B, Pan SH, Chen H, Kong R, Li J, Xue DB, Bai XW, Jiang HC. Wang SJ, et al. Zhonghua Wai Ke Za Zhi. 2010 Apr 1;48(7):530-4. Zhonghua Wai Ke Za Zhi. 2010. PMID: 20646665 Chinese.

8

Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway.

Wang SJ, Sun B, Cheng ZX, Zhou HX, Gao Y, Kong R, Chen H, Jiang HC, Pan SH, Xue DB, Bai XW. Wang SJ, et al. Cancer Chemother Pharmacol. 2011 Dec;68(6):1421-30. doi: 10.1007/s00280-011-1643-7. Epub 2011 Apr 9. Cancer Chemother Pharmacol. 2011. PMID: 21479633

9

Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions.

Cheng ZX, Sun B, Wang SJ, Gao Y, Zhang YM, Zhou HX, Jia G, Wang YW, Kong R, Pan SH, Xue DB, Jiang HC, Bai XW. Cheng ZX, et al. Among authors: wang yw, wang sj. PLoS One. 2011;6(8):e23752. doi: 10.1371/journal.pone.0023752. Epub 2011 Aug 22. PLoS One. 2011. PMID: 21887310 Free PMC article.

10

Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo.

Wang YW, Wang SJ, Zhou YN, Pan SH, Sun B. Wang YW, et al. Among authors: wang sj. J Cancer Res Clin Oncol. 2012 May;138(5):785-97. doi: 10.1007/s00432-012-1152-z. Epub 2012 Jan 24. J Cancer Res Clin Oncol. 2012. PMID: 22270965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,331 results

Search Page

Filters